about
Gros1, a potential growth suppressor on chromosome 1: its identity to basement membrane-associated proteoglycan, leprecanDuplication of a genomic region containing the Cdc2L1-2 and MMP21-22 genes on human chromosome 1p36.3 and their linkage to D1Z2An alternative pathway for gene regulation by MycSestrins at the crossroad between stress and agingExpression of SMARCF1, a truncated form of SWI1, in neuroblastomap53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signalingHuman acid ceramidase is overexpressed but not mutated in prostate cancerBiallelic inactivation of the RIZ1 gene in human gastric cancerGenomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2A novel gene family NBPF: intricate structure generated by gene duplications during primate evolutionFailure to proliferate and mitotic arrest of CDK11(p110/p58)-null mutant mice at the blastocyst stage of embryonic cell developmentp53 and microRNA-34 are suppressors of canonical Wnt signaling.A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genesIdentification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.p73: structure and function.A genome screen of multiplex sibships with prostate cancer.Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoterNovel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.Neuroblastoma tumour genetics: clinical and biological aspects.Sestrin2 protein positively regulates AKT enzyme signaling and survival in human squamous cell carcinoma and melanoma cells.Combined karyotyping, CGH and M-FISH analysis allows detailed characterization of unidentified chromosomal rearrangements in Merkel cell carcinoma.A genome-wide investigation of copy number variation in patients with sporadic brain arteriovenous malformation.Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomasUse of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies.The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressorAdverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer.Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression.Atrophin proteins: an overview of a new class of nuclear receptor corepressorsNeuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum.MiRNA-34 intrinsically links p53 tumor suppressor and Wnt signaling.Mutation analysis of P73 and TP53 in Merkel cell carcinomaDistinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.The RUNX family: developmental regulators in cancer.Characterization of chromosome 1 abnormalities in malignant melanomas.EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.RUNX3 is a prognostic marker and potential therapeutic target in human breast cancer.Runx Genes in Breast Cancer and the Mammary Lineage.KIF1Bbeta functions as a haploinsufficient tumor suppressor gene mapped to chromosome 1p36.2 by inducing apoptotic cell death.Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
P2860
Q24290125-19D782A0-D9C7-434E-9E6F-060CCBD89BD1Q24316300-16911381-1578-41C6-86E5-89C4A0E88498Q24532791-48DBF297-BDB3-481D-AFDC-B8CB7796878FQ24633564-4FBFA723-073C-41D3-8021-DA7D8D927F29Q24685907-3AC646DC-C992-4927-8631-7C686E1877D5Q28117922-A7BF8BEF-9E09-4CD5-96ED-A0D0A337C0B8Q28144553-054D82B6-98B3-4E28-A9D0-6AF3713A2A3EQ28208181-C956616D-0070-44A3-8587-F48C59CF031AQ28214616-3CC6D4C7-73AE-4062-9049-3615C878E3CEQ28265563-F64D8E03-51B2-4B8F-9376-442433D31B31Q28585216-A166AFBD-AF99-4E79-B7C6-B6BBD4BC77E5Q30424916-CE743F84-6E46-4C7C-A297-ACF229337181Q33336547-32806595-8A04-4BAC-9F53-C7631C77E9A4Q33917281-2C89CECF-E8A8-4900-ADE5-B66F4CE055BBQ34023178-68131AA7-195A-4C1C-8BD7-DD72754F6065Q34145438-B768B6CC-5EA9-42EC-A3B2-ECBAEF21B4D7Q34197920-6285333B-0FB3-4471-BF8B-B4F041B3EB74Q34277205-5FBBF047-CAAE-42D3-B5C9-408CFCF18571Q34442835-8889F68C-6E15-40E3-AF1A-C3C0ECD93EEEQ34453849-6BD3BC8E-4030-460E-AA1D-0BE836FF5874Q34774451-C05A7831-5FCC-44EC-9948-5E3EE2C804F7Q34810928-E5FCC767-4698-4395-960C-ACF7122DEF98Q35008897-7FA12077-60A3-48DD-A089-75EB4611DE26Q35747010-74BDBC22-5D86-423A-993B-69EACDE8AE51Q35787273-C8C4A97B-D9E3-40B5-B5EC-97A3BE91D049Q36517840-5E1AE92B-EDEB-44EE-B51F-1A22256E8362Q36667498-CC3214EC-EE92-4BEB-A965-0BD1E30F0FB8Q36830940-AAA9FEBB-6433-4199-824E-6C6D0674098DQ36980650-D8F6A7DF-C627-4385-BE01-AD77F51B6E70Q37582476-A25F9BAF-6841-4E53-B34A-25D5925347C5Q37993984-6C7F256C-9EFC-415A-B58B-0A519E2D8EA1Q38274116-D6A0EFD5-6FD9-49B8-90BA-B6A6A233E84FQ38305367-6574D7C7-8D7F-451C-8CF0-DE4536564B81Q38319972-BFCCAA48-6266-4E77-B350-55714B30B01FQ38497220-C8781300-78A2-48EA-9669-8436DB974AB0Q38748250-A9C34393-5D60-48F4-A319-182E65BFBA7BQ39100545-2880BC4F-B3B2-41C1-AEB2-D1FC83AC7DB1Q39181420-EE6CA986-AD55-44AA-82EF-A87DB24E6595Q39963322-51D5CAA5-E5DE-47FE-BEBF-39812CC058B9Q40040255-55667667-D378-4E5A-ADB1-9DF9D10776E1
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Genomic instability in 1p and human malignancies.
@en
type
label
Genomic instability in 1p and human malignancies.
@en
prefLabel
Genomic instability in 1p and human malignancies.
@en
P2093
P2860
P1476
Genomic instability in 1p and human malignancies.
@en
P2093
P2860
P304
P356
10.1002/(SICI)1098-2264(199608)16:4<211::AID-GCC1>3.0.CO;2-0
P577
1996-08-01T00:00:00Z